DHHC PATs can predominantly exhibit either oncogenic or tumor suppressor function in specific cancers; e.g., ZDHHC2 as a tumor suppressor in breast, lung, and prostate tumors 28-30. This evidence concerns the gene ZDHHC2 and cancer.